FDA News
Botox Receives FDA Approval for Treating Crow’s Feet
According to a September 11, 2013 CBS News report entitled “Botox Now FDA-Approved for Treating Crow’s Feet,” Botox had been officially approved for Crow’s feet, which are wrinkles at the outside corners of the eyes. OnabotulinumtoxinA, known by the trade name ‘Botox’, is made from the same neurotoxin which can cause food-borne botulism. When this […]
FDA, Allergan warn of foreign Botox in counterfeit packaging sold to U.S. docs
A new wrinkle has developed in the fight by the FDA against counterfeit drugs. An unapproved, foreign version of the cosmetic treatment Botox has shown up in the U.S., this time in counterfeit packaging that makes it appear to be the same product that is made for the U.S. market. The agency said in a […]
BELOTERO BALANCE® Dermal Filler Is Now Available Nationwide
Hyaluronic Acid (HA) Based Dermal-Filler Provides Soft, Natural-Looking, Long-Lasting Results in a Safe and Quick Procedure Merz, Inc. through its aesthetics division, Merz Aesthetics, Inc., today announced the nationwide availability of BELOTERO BALANCE® Dermal Filler, a natural-looking, long-lasting dermal filler that was approved by the Food and Drug Administration (FDA) in November 2011 as a […]
FDA Approves Diet Drug Qsymia
For the second time in less than a month, the FDA has approved a new prescription weight loss drug. Qsymia, developed by California-based Vivus Inc., combines two already prescribed medications — the stimulant phentermine and the anti-seizure drug Topamax (topiramate) — in a controlled-release pill that is taken once a day. Last February, an FDA […]
Arena Pharmaceuticals and Eisai Announce FDA Approval of BELVIQ® (lorcaserin HCl) for Chronic Weight Management in Adults who are Overweight with a Comorbidity or Obese
First Prescription Weight-Loss Treatment Approved by FDA in 13 Years Eisai to Launch BELVIQ in U.S. Following DEA’s Completion of Scheduling Review Arena Pharmaceuticals, Inc.(NASDAQ: ARNA) andEisai Inc.announced today that theU.S. Food and Drug Administration(FDA) has approved BELVIQ (pronounced BEL-VEEK) as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management […]
FDA, FTC act to remove “homeopathic” HCG weight loss products from the market
Joint action is first step in halting sale of the products. The U.S. Food and Drug Administration and the Federal Trade Commission (FTC) today issued seven Warning Letters to companies marketing over-the counter (OTC) HCG products that are labeled as “homeopathic” for weight loss. Human chorionic gonadotropin (HCG) is a hormone produced by the human […]
New Alternative to Botox Approved
Aside from plastic surgery, Botox has been the best anti-aging weapon up until now. However, that’s about to change as a new Botox alternative called LAVIV has been approved by the FDA. Learn more about this promising alternative that uses your own cells to help you look and feel younger. Loved or, on the contrary, […]
FDA approves Botox for loss of bladder control
U.S. drug regulators approved Allergan’s Botox for treating a specific kind of overactive bladder on Wednesday, setting the stage for wider use of the popular wrinkle treatment in those with bladder problems.The U.S. Food and Drug Administration said Botox can be injected into the bladder to treat those who lose bladder control because of damage […]
FDA OKs Xeomin for frown lines
The Food and Drug Administration (FDA) has approved Xeomin (incobotulinumtoxinA, Merz Aesthetics) for temporary improvement of moderate to severe glabellar lines, Medscape Today reports. According to a Merz statement, the approval is based on the results of two multicenter U.S. clinical trials involving 547 healthy adults. In both studies, Xeomin injections significantly improved the appearance […]
Allergan Receives FDA Approval for First-of-Its-Kind, Fully in vitro, Cell-Based Assay for BOTOX® and BOTOX® Cosmetic (onabotulinumtoxinA)
–Represents R&D Breakthrough in Commitment to Animal-Free Stability and Potency Testing for BOTOX® and BOTOX® Cosmetic– IRVINE, Calif.–(BUSINESS WIRE)– Allergan, Inc. (NYSE:AGN) today announced the United States Food and Drug Administration (FDA) has approved a fully in vitro, cell-based assay for use in the stability and potency testing of BOTOX® (onabotulinumtoxinA) and BOTOX® Cosmetic. […]
